PLIANT THERAPEUTICS, INC. Capital Expenditures Incurred but Not yet Paid
PLIANT THERAPEUTICS, INC. (PLRX) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-11
- PLIANT THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $0.00.
- PLIANT THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PLIANT THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- PLIANT THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $0.00.
- PLIANT THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $112.00K, a 52.54% decline from fiscal 2024.
- PLIANT THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $236.00K.
- PLIANT THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $0.00.
- PLIANT THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | -$20.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | -$20.00K derived: sum of 3 quarters · filed 2026-08-11 | $112.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$20.00K derived: sum of 2 quarters · filed 2026-08-11 | $112.00K 10-Q · filed 2025-11-06 | $216.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $112.00K 10-Q · filed 2026-08-11 | $216.00K derived: sum of 3 quarters · filed 2026-08-11 | $128.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $132.00K 10-Q · filed 2026-05-11 | $236.00K derived: sum of 2 quarters · filed 2026-05-11 | $148.00K derived: sum of 3 quarters · filed 2026-05-11 | -$691.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $16.00K derived: sum of 2 quarters · filed 2026-03-11 | -$823.00K derived: sum of 3 quarters · filed 2026-03-11 | $236.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | -$88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$927.00K derived: sum of 2 quarters · filed 2025-11-06 | $132.00K 10-Q · filed 2025-11-06 | $132.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$839.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $220.00K 10-Q · filed 2025-08-07 | $220.00K derived: sum of 3 quarters · filed 2025-08-07 | $210.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.06M 10-Q · filed 2025-05-08 | $1.06M derived: sum of 2 quarters · filed 2025-05-08 | $1.05M derived: sum of 3 quarters · filed 2025-05-08 | $1.06M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$10.00K derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 |
| 2023-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | -$33.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $10.00K 10-Q · filed 2024-08-07 | -$23.00K derived: sum of 3 quarters · filed 2025-03-03 | $10.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-06 | -$33.00K derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | |
| 2022-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | |
| 2022-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $33.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | -$273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$25.00K derived: sum of 2 quarters · filed 2024-02-27 | $57.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | $248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $330.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $82.00K 10-Q · filed 2022-08-08 | |||
| 2020-12-31 | $188.00K 10-K · filed 2022-03-01 | |||
| 2019-12-31 | $159.00K 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |